Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Geynisman

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
AI Policy in JNCCNDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|April 5, 2026
Hello JNCCN ReadersDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
A New Administration and JNCCNDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Hope and Uncertainty in Advanced CancersDaniel M Geynisman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
When Patients LeaveDaniel M Geynisman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Doctor, where art thou?Daniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2026
Curing Prostate Cancer?Daniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2025
A Difficult ConversationDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|October 9, 2025
Prostate Cancer 2025Daniel M Geynisman
European Urology|July 22, 2015
Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid FeaturesDaniel M Geynisman
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
AI Policy in JNCCNDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|April 5, 2026
Hello JNCCN ReadersDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
A New Administration and JNCCNDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Hope and Uncertainty in Advanced CancersDaniel M Geynisman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
When Patients LeaveDaniel M Geynisman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Doctor, where art thou?Daniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2026
Curing Prostate Cancer?Daniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2025
A Difficult ConversationDaniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN|October 9, 2025
Prostate Cancer 2025Daniel M Geynisman
European Urology|July 22, 2015
Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid FeaturesDaniel M Geynisman
Pageof 19